No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:113464200-113486400 |
Weak transcription |
Primary mononuclear cells fromperipheralblood |
Blood
|
2 |
chr2:113469400-113484200 |
Weak transcription |
Right Atrium |
heart
|
3 |
chr2:113472400-113483000 |
Weak transcription |
Spleen |
Spleen
|
4 |
chr2:113477600-113487000 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
5 |
chr2:113478400-113483800 |
Weak transcription |
Primary neutrophils fromperipheralblood |
blood
|
6 |
chr2:113478600-113488200 |
Weak transcription |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
7 |
chr2:113479400-113485200 |
Enhancers |
K562 |
blood
|
8 |
chr2:113480000-113488200 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
9 |
chr2:113481200-113487600 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
10 |
chr2:113481600-113483000 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
11 |
chr2:113481800-113484400 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
12 |
chr2:113481800-113486600 |
Enhancers |
Placenta |
Placenta
|
13 |
chr2:113482000-113483200 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
14 |
chr2:113482000-113483600 |
Enhancers |
GM12878-XiMat |
blood
|
15 |
chr2:113482000-113483800 |
Weak transcription |
Colonic Mucosa |
Colon
|
16 |
chr2:113482200-113483000 |
Weak transcription |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
17 |
chr2:113482200-113484400 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
18 |
chr2:113482200-113484800 |
Enhancers |
Primary B cells from peripheral blood |
blood
|
19 |
chr2:113482200-113485000 |
Enhancers |
Hela-S3 |
cervix
|
20 |
chr2:113482200-113485200 |
Enhancers |
HMEC |
breast
|
21 |
chr2:113482400-113483000 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
22 |
chr2:113482400-113484000 |
Flanking Bivalent TSS/Enh |
HepG2 |
liver
|
23 |
chr2:113482400-113484800 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
24 |
chr2:113482400-113484800 |
Enhancers |
Fetal Intestine Large |
intestine
|
25 |
chr2:113482400-113484800 |
Enhancers |
Fetal Intestine Small |
intestine
|
26 |
chr2:113482600-113483000 |
Active TSS |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
27 |
chr2:113482600-113483600 |
Weak transcription |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
28 |
chr2:113482600-113484000 |
Weak transcription |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
29 |
chr2:113482600-113484200 |
Weak transcription |
HUES6 Cell Line |
embryonic stem cell
|
30 |
chr2:113482600-113484400 |
Enhancers |
A549 |
lung
|
31 |
chr2:113482600-113484800 |
Enhancers |
NHEK |
skin
|
32 |
chr2:113482800-113483600 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
33 |
chr2:113482800-113483800 |
Weak transcription |
ES-I3 Cell Line |
embryonic stem cell
|
34 |
chr2:113482800-113483800 |
Weak transcription |
Primary Natural Killer cells fromperipheralblood |
blood
|
35 |
chr2:113482800-113484000 |
Weak transcription |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
36 |
chr2:113482800-113484800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|